Search - tctmd.com

Displaying 101 - 120 of 134

Sort: Relevancy | Date

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

L.A. McKeown

July 25, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

News Features

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Caitlin E. Cox

June 14, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

News Daily News

Certain Periprocedural MIs Don’t Matter, New Data Allege

Michael O'Riordan

May 09, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

News Daily News

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

Todd Neale

April 26, 2024

News Daily News

New Heart Failure After AF Diagnosis Merits More Attention

Todd Neale

April 18, 2024

Presentation Fellows 2024

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: David J. Cohen

April 12, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

Presentation ACC 2024

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Presenter: Gervasio A. Lamas

April 07, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Advertisement

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Certain Periprocedural MIs Don’t Matter, New Data Allege

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

AF Patients Under Age 65 Have High Risk Factor Burden, More Adverse Outcomes

New Heart Failure After AF Diagnosis Merits More Attention

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Telemedicine Strategy After MI Scores a Win in TELE-ACS

The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content